Immunohematology

Keyphrases

Publications

volume 39, number 1, 2023

J W Jacobs, E Abels, T C Binns, C A Tormey, N Sostin
Hemolytic disease of the fetus and newborn mediated by anti-Di a in a U.S. hospital. Immunohematology 39 (1) (2023)
X Yang, J M Syrjamaki, P A Ruegsegger, C T Rohrer, W N Rose
Practical evaluation of a warm-reactive anti-M. Immunohematology 39 (1) (2023)
D S Parchure, G V Mishra, S S Kulkarni
Overview of the serologic and molecular basis of D variants with a focus on D variants in the Indian population. Immunohematology 39 (1) (2023)
S Sawadogo, K Nebie, S K A Ouedraogo, C Traore, J Koulidiati, M Nikiema-Minoungou, N G Koala, E Kafando, V Deneys
Extended red blood cell antigens and phenotypes in Burkina Faso: potential issues to design local population-sourced red blood cell reagent panels. Immunohematology 39 (1) (2023)
D Sahoo, S Anuragaa, B Abhishekh
Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report. Immunohematology 39 (1) (2023)
L Stenfelt, Å Hellberg, M L Olsson
SID: a new carbohydrate blood group system based on a well-characterized but still mysterious antigen of great pathophysiologic interest. Immunohematology 39 (1) (2023)

volume 39, number 2, 2023

E C McGowan, J R Storry
The LW blood group system: not just "tagging along" with D. Immunohematology 39 (2) (2023)
S J T Nance
The monocyte monolayer assay, an in vitro method for prediction of in vivo survival of transfused incompatible red blood cells: a review. Immunohematology 39 (2) (2023)
C E George, S Grimsley, R Cumber, N Thornton, H Davies, C Harris, E Massey, K Perera
Transfusion of incompatible blood to a patient with alloanti-Sc1. Immunohematology 39 (2) (2023)
K Bowman, L A Peña Marquez, L Hawthorne, K Billingsley, S Kelham, S Liang, M Kalvelage
A comparison of results from antihuman globulin-graded reactions with the monocyte monolayer assay. Immunohematology 39 (2) (2023)
J Novoselac, K Buzina Marić, V Rimac, I Selak, M Raos, B Golubić Ćepulić
Significance of immunohematologic testing in mother and newborn ABO incompatibility. Immunohematology 39 (2) (2023)

volume 39, number 3, 2023

Gwen Clarke, Jelena Holovati
The Specialist in Transfusion Science program. Immunohematology 39 (3) (2023)
Peter D Issitt
Peter D. Issitt (1933-2023). Immunohematology 39 (3) (2023)
G M Meny, M A Keller, C Flickinger
Update on programs for achieving Specialist in Blood Banking certification in the United States: 2023. Immunohematology 39 (3) (2023)
Susan T Johnson
Proud to be a medical laboratory scientist. Immunohematology 39 (3) (2023)
T C S Silva, M R Dezan, B R Cruz, S S M Costa, C L Dinardo, J O Bordin
Standardization of a multiplex assay to identify weak D types in a mixed-race Brazilian population. Immunohematology 39 (3) (2023)

volume 33, number 4, 2023

T Horn, J Hamilton, J Kosanke, V W Hare, W Kluver, W Beres, S Nance, M A Keller
Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype. Immunohematology 33 (4) (2023)

volume 38, number 1, 2022

K Srivastava, M U Bueno, W A Flegel
Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans . Immunohematology 38 (1) (2022)
N García-Tardón, J M M Rondeel, F Danovic, J S Luken, A Winters, P C Ligthart, M De Haas, G Den Besten
Unexpected antibody against the high-prevalence P antigen before cardiac surgery. Immunohematology 38 (1) (2022)
T R Wafford
Use of thiol reagents to disperse cold autoagglutination. Immunohematology 38 (1) (2022)
R G Gheshlagh, M Ansari, P Dalvand, F Shabani, A N Albatineh
Association between ABO blood group and COVID-19 infection: an updated systematic review and meta-analysis. Immunohematology 38 (1) (2022)
E P Chennamsetty, A Jain, D Kaur, S K Meinia, G Negi, S Agarwal, J Deb
Life-saving transfusion in autoimmune hemolytic anemia: a case report and procedure review of the dilution method. Immunohematology 38 (1) (2022)

volume 38, number 2, 2022

Alexandre Geraldo, Larissa Sbors, Flávia Martinello
The effect of probiotic use on ABO antibody titers. Immunohematology 38 (2) (2022)
T R Wafford, L P Walker
Prevalence of Rh, Kell, Kidd, Duffy, and MNS antigens in the Hispanic donor population of South Texas. Immunohematology 38 (2) (2022)
Karen M Byrne, Ashley A Collins, Robel Seifu, Traci D Paige, Willy A Flegel
Using social media to recruit for a face-to-face Specialist in Blood Bank (SBB) Technology program. Immunohematology 38 (2) (2022)
S Yearout, A Smith, J Keller, M A Keller
Novel KEL allele associated with loss of Kp b identified in a white blood donor. Immunohematology 38 (2) (2022)

volume 38, number 3, 2022

S S Das, S Mukherjee, A Chakrapani, D Bhattacharyya
Clinical perspectives, immunohematologic insights, and transfusion management in IgA-associated autoimmune hemolytic anemia. Immunohematology 38 (3) (2022)
S Phou, N Nguyen, J Revilla, K Rodberg, D R Gibb, S H Pepkowitz, E B Klapper
Investigating anti-D in an individual with the weak D type 2 genotype. Immunohematology 38 (3) (2022)
A Mathur, A Jindal, A K Tiwari, D Bhuyan, L Jagannathan, R B Sawant, S Basu, M Reddy, S S Datta
A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population. Immunohematology 38 (3) (2022)
B Bruce
Enzyme treatment of red blood cells: use of ficin and papain. Immunohematology 38 (3) (2022)
Kingsley C Nnawuba, Benjamin M Boral, Robert W Donnell
Probable warm autoimmune hemolytic anemia proceeding the administration of the Pfizer mRNA COVID-19 vaccine. Immunohematology 38 (3) (2022)
J V Rodriguez, C A Tormey
Procuring rare (しい)* Japanese red blood cell units for a bleeding patient with anti-K11 requiring a life-saving procedure. Immunohematology 38 (3) (2022)

volume 38, number 4, 2022

Margaret A Keller, Cynthia Flickinger
To contributors to the 2022 issues. Immunohematology 38 (4) (2022)
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Post COVID-19 vaccination and adverse events: correspondence. Immunohematology 38 (4) (2022)
Sheetal Malhotra, Ashish Jain, Ratti Ram Sharma, Srinivasan Peyam
Rare case of clinically significant anti-c in a 1-year-old pediatric patient. Immunohematology 38 (4) (2022)
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Post COVID-19 vaccination and adverse events: correspondence. Immunohematology 38 (4) (2022)
M D Ilsley, J R Storry, M L Olsson
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system. Immunohematology 38 (4) (2022)
Sandra Nance
Use of e VAR and anti-e VAR as interim terms. Immunohematology 38 (4) (2022)
M D Ilsley, J R Storry, M L Olsson
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system. Immunohematology 38 (4) (2022)
Sandra Nance
Use of e VAR and anti-e VAR as interim terms. Immunohematology 38 (4) (2022)
M D Ilsley, J R Storry, M L Olsson
Yes, MAM: how the cancer-related EMP3 protein became a regulator of erythropoiesis and the key protein underlying a new blood group system. Immunohematology 38 (4) (2022)
C P Arnoni, T A P Vendrame, F S Silva, A J P Cortez, F R M Latini, L Castilho
RHCE variant alleles and risk of alloimmunization in Brazilians. Immunohematology 38 (4) (2022)
H Ohto, M Uchikawa, S Ito, I Wada, K E Nollet, Y Omae, K Ogasawara, K Tokunaga
The KANNO blood group system. Immunohematology 38 (4) (2022)
Sheetal Malhotra, Ashish Jain, Ratti Ram Sharma, Srinivasan Peyam
Rare case of clinically significant anti-c in a 1-year-old pediatric patient. Immunohematology 38 (4) (2022)
C P Arnoni, T A P Vendrame, F S Silva, A J P Cortez, F R M Latini, L Castilho
RHCE variant alleles and risk of alloimmunization in Brazilians. Immunohematology 38 (4) (2022)
H Ohto, M Uchikawa, S Ito, I Wada, K E Nollet, Y Omae, K Ogasawara, K Tokunaga
The KANNO blood group system. Immunohematology 38 (4) (2022)
Margaret A Keller, Cynthia Flickinger
To contributors to the 2022 issues. Immunohematology 38 (4) (2022)

volume 37, number 2, 2022

Sheetal Malhotra, Ashish Jain, Sirat Kaur, Alakananda Walia, Lakhvinder Singh, Ratti Ram Sharma
An interesting case of alloanti-M exhibiting typical dosage phenomenon. Immunohematology 37 (2) (2022)
Sheetal Malhotra, Ashish Jain, Sirat Kaur, Alakananda Walia, Lakhvinder Singh, Ratti Ram Sharma
An interesting case of alloanti-M exhibiting typical dosage phenomenon. Immunohematology 37 (2) (2022)
Sheetal Malhotra, Ashish Jain, Sirat Kaur, Alakananda Walia, Lakhvinder Singh, Ratti Ram Sharma
An interesting case of alloanti-M exhibiting typical dosage phenomenon. Immunohematology 37 (2) (2022)